Bioenterprise Capital Ventures Bioenterprise Trans-Atlantic Agri-Technology Fund
Product Details
Product Name: Bioenterprise Trans-Atlantic Agri-Technology Fund
Overview: Bioenterprise Capital invests in carefully selected agri-based technologies and businesses that promote human health, lower global energy consumption, reduce the environmental impact of industry and lever technology to materially impact productivity.
Issues Focused: Affordable and Clean Energy, Climate Action
Asset Class: Other Real Assets
Geography: Canada
Impact Measurement
IRIS 4.0 Social Impact Objectives: Access to Clean Water, Agricultural Productivity, Food Security, Health
IRIS 4.0 Environmental Impact Objectives: Energy and Fuel Efficiency, Sustainable Energy, Sustainable Land Use, Water Resource Management
IRIS 4.0 Targets:
Impact Evidence Type: Not Specified
Bioenterprise Capital Ventures

Last updated by Bioenterprise Capital Ventures on 05 Nov 16:47

Investment Details
Legal Structure: Limited Partnership
Product Stage: Not Specified
Part of Series: First
Investment Availability: Closed
Minimum Investment: $5,000,000
Investor Eligibility: Foundations/Endowments, Accredited Investors
Assets Under Management: AUM > $50M
Average Management Fees %:
Average Performance Expectations: Expectations ≥ 12%
Performance To Date: Above Expectations